;
Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • International Stem Cell gene/cell therapy news

    International Stem Cell Corp. (OTCBB:ISCO), Carlsbad, Calif. Business: Gene/Cell therapy Advocate General Cruz Villalon from the European Court of Justice issued an opinion arguing that an ovum whose development has …

    Published on 7/21/2014
  • Reaction Biology, NIH other news

    Reaction Biology Corp., Malvern, Pa. National Institutes of Health, Bethesda, Md. Business: Other Reaction Biology received a Phase I Small Business Innovation Research (SBIR) grant totaling $287,650 from the NIHs …

    Published on 7/21/2014
  • Shire, Sanofi, Icahn School of Medicine at Mount Sinai, Knowledge Ecology International endocrine/metabolic news

    Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Icahn School of Medicine at Mount Sinai, New York, N.Y. Knowledge Ecology International, Washington, D.C. Business: …

    Published on 7/21/2014
  • Vertex, U.S. Centers for Medicare & Medicaid Services pulmonary news

    Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), Boston, Mass. U.S. Centers for Medicare & Medicaid Services (CMS), Baltimore, Md. Business: Pulmonary Three cystic fibrosis patients filed suit in the U.S. District Court for …

    Published on 7/21/2014
  • Aastrom Biosciences Inc gene/cell therapy, dermatology news

    Aastrom Biosciences Inc. (NASDAQ:ASTM), Ann Arbor, Mich. Business: Gene/Cell therapy, Dermatology Aastrom will discontinue manufacturing of MACI matrix-induced autologous chondrocyte implant in Denmark. Aastrom said its…

    Published on 7/14/2014
  • Breckenridge Pharmaceutical Inc, Teva, Natco cancer news

    Breckenridge Pharmaceutical Inc., Boca Raton, Fla. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Natco Pharma Ltd. (BSE:NATCO; NSE:NATCOPHARM), Hyderabad, India Business: Cancer Tevas Cephalon Inc…

    Published on 7/14/2014
  • Bristol-Myers Squibb Co, Duke University pharmaceuticals news

    Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Duke University, Durham, N.C. Business: Pharmaceuticals Bristol-Myers will provide access to information from company-sponsored trials through Dukes CRO Duke Clinical …

    Published on 7/14/2014
  • Cancer Research U cancer news

    Cancer Research UK, London, U.K. Business: Cancer Cancer Research UK announced its Programme Foundation Award, which will provide funding of up to L1.5 million ($2.6 million) over six years to mid-career scientists at U…

    Published on 7/14/2014
  • Cellular Biomedicine Group Inc gene/cell therapy news

    Cellular Biomedicine Group Inc. (NASDAQ:CBMG), Palo Alto, Calif. Business: Gene/Cell therapy Cellular Biomedicine discontinued its consulting business segment after an internal business review and said it is now a pure-…

    Published on 7/14/2014
  • Cepheid Inc, Cubist, AstraZeneca, GlaxoSmithKline diagnostic news

    Cepheid Inc. (NASDAQ:CPHD), Sunnyvale, Calif. Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business:…

    Published on 7/14/2014
  • Cold Spring Harbor Laboratory genomics news

    Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. Business: Genomics Cold Spring Harbor received a $50 million gift from Jim and Marilyn Simons to establish the Simons Center for Quantitative Biology, which will …

    Published on 7/14/2014
  • Eli Lilly and Co, Sanofi endocrine/metabolic news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Endocrine/Metabolic Sanofi filed suit in the U.S. District Court for the District of Delaware against Eli Lilly …

    Published on 7/14/2014
  • Express Scripts Holding Co supply/service news

    Express Scripts Holding Co. (NASDAQ:ESRX), St. Louis, Mo. Business: Supply/Service Express Scripts said it will begin blocking coverage this month for more than 1,000 ingredients used in compounding medications. The …

    Published on 7/14/2014
  • Pfizer Inc, Monash University pharmaceuticals news

    Pfizer Inc. (NYSE:PFE), New York, N.Y. Monash University, Victoria, Australia Business: Pharmaceuticals The university partnered with Pfizer under the pharmas Global Center for Therapeutic Innovation initiative. Pfizer …

    Published on 7/14/2014
  • Shire pl, Actavis, Amneal Pharmaceuticals, Boehringer Ingelheim, Mylan, Novartis neurology news

    Shire plc (LSE:SHP; NASDAQ:SHPG), Dublin, Ireland Actavis plc (NYSE:ACT), Dublin, Ireland Amneal Pharmaceuticals LLC, Bridgewater, N.J. Boehringer Ingelheim GmbH, Ingelheim, Germany Mylan Inc. (NASDAQ:MYL), …

    Published on 7/14/2014
  • Takeda Pharmaceutical Co. Ltd cardiovascular news

    Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Cardiovascular Takeda said law firm Jones Day, a third-party investigator, did not find evidence that the pharma falsified or fabricated data or had …

    Published on 7/14/2014
  • Teva Pharmaceutical Industries Ltd, U.S. Food and Drug Administration neurology, generics news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel U.S. Food and Drug Administration (FDA), Silver Spring, Md. Business: Neurology, Generics Teva said it filed its seventh Citizens Petition asking FDA …

    Published on 7/14/2014
  • Zogenix Inc neurology news

    Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. Business: Neurology The U.S. District Court in Massachusetts granted a preliminary injunction that lifted some state restrictions for prescribing Zogenixs Zohydro ER …

    Published on 7/14/2014
  • Araclon Biotech S.L, Ixico, SomaLogic, AstraZeneca, GlaxoSmithKline, J&J, Alzheimers Research U.K. neurology news

    Araclon Biotech S.L., Zaragoza, Spain Ixico plc (LSE:IXI), London, U.K. SomaLogic Inc., Boulder, Colo. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Johnson & …

    Published on 6/23/2014
  • Biota Pharmaceuticals Inc, U.S. Department of Health and Human Services infectious news

    Biota Pharmaceuticals Inc. (NASDAQ:BOTA), Alpharetta, Ga. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Biota will reduce headcount by 50 (67%) to 25 and close its Melbourne …

    Published on 6/23/2014
  • Cortexyme Inc, EpiBone, G-Tech gastrointestinal, musculoskeletal, neurology news

    Cortexyme Inc., San Francisco, Calif. EpiBone Inc., New York, N.Y. G-Tech, Palo Alto, Calif. Business: Gastrointestinal, Musculoskeletal, Neurology The companies each received a $350,000 award from the Thiel Foundations…

    Published on 6/23/2014
  • Gilead Sciences Inc infectious news

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Infectious Reps. Henry Waxman (D-Calif.) and Diana DeGette (D-Colo.) wrote to House Energy and Commerce Committee majority leadership to request a …

    Published on 6/23/2014
  • Maxygen Inc other news

    Maxygen Inc., San Mateo, Calif. Business: Other Maxygens board approved a second and final liquidating distribution of $0.09 per share, to be paid on or about June 30. Shareholders received an initial payout of $69.5 …

    Published on 6/23/2014
  • Merck & Co. endocrine/metabolic news

    Merck & Co. (NYSE:MRK), Whitehouse Station, N.J. Business: Endocrine/Metabolic Merck launched a global prospective registry to evaluate the outcomes of about 20,000 Type II diabetics in real-word settings. The registry …

    Published on 6/23/2014
  • Myriad Genetics Inc, Pathway Genomics diagnostic news

    Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Pathway Genomics Corp., San Diego, Calif. Business: Diagnostic Myriad filed suit against Pathway in the U.S. District Court for the District of Utah, Central …

    Published on 6/23/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993